Your browser doesn't support javascript.
loading
Impact of daily plan adaptation on accumulated doses in ultra-hypofractionated magnetic resonance-guided radiation therapy of prostate cancer.
Xiong, Yuqing; Rabe, Moritz; Rippke, Carolin; Kawula, Maria; Nierer, Lukas; Klüter, Sebastian; Belka, Claus; Niyazi, Maximilian; Hörner-Rieber, Juliane; Corradini, Stefanie; Landry, Guillaume; Kurz, Christopher.
Afiliação
  • Xiong Y; Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.
  • Rabe M; Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.
  • Rippke C; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
  • Kawula M; Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.
  • Nierer L; Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.
  • Klüter S; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
  • Belka C; Heidelberg Institute of Radiation Oncology, National Center for Radiation Oncology, Heidelberg, Germany.
  • Niyazi M; Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.
  • Hörner-Rieber J; German Cancer Consortium (DKTK), Partner site Munich, a Partnership between DKFZ and LMU University Hospital Munich, Germany.
  • Corradini S; Bavarian Cancer Research Center (BZKF), Munich, Germany.
  • Landry G; Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.
  • Kurz C; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
Phys Imaging Radiat Oncol ; 29: 100562, 2024 Jan.
Article em En | MEDLINE | ID: mdl-38463219
ABSTRACT
Background and

purpose:

Ultra-hypofractionated online adaptive magnetic resonance-guided radiotherapy (MRgRT) is promising for prostate cancer. However, the impact of online adaptation on target coverage and organ-at-risk (OAR) sparing at the level of accumulated dose has not yet been reported. Using deformable image registration (DIR)-based accumulation, we compared the delivered adapted dose with the simulated non-adapted dose. Materials and

methods:

Twenty-three prostate cancer patients treated at two clinics with 0.35 T magnetic resonance-guided linear accelerator (MR-linac) following the same treatment protocol (5 × 7.5 Gy with urethral sparing and daily adaptation) were included. The fraction MR images were deformably registered to the planning MR image. Both non-adapted and adapted fraction doses were accumulated with the corresponding vector fields. Two DIR approaches were implemented. PTV* (planning target volume minus urethra+2mm) D95%, CTV* (clinical target volume minus urethra) D98%, and OARs (urethra+2mm, bladder, and rectum) D0.2cc, were evaluated. Statistical significance was inferred from a two-tailed Wilcoxon signed-rank test (p < 0.05).

Results:

Normalized to the baseline, the accumulated PTV* D95% increased significantly by 2.7 % ([1.5, 4.3]%) through adaptation, and the CTV* D98% by 1.2 % ([0.1, 1.7]%). For the OARs after adaptation, accumulated bladder D0.2cc decreased by 0.4 % ([-1.2, 0.4]%), urethra+2mmD0.2cc by 0.8 % ([-1.6, -0.1]%), while rectum D0.2cc increased by 2.6 % ([1.2, 4.9]%). For all patients, rectum D0.2cc was still below the clinical constraint. Results of both DIR approaches differed on average by less than 0.2 %.

Conclusions:

Online adaptation in MRgRT improved target coverage and OARs sparing at the level of accumulated dose.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article